• sales@syndicatedanalytics.com
  • +1-213-316-7435

GCC Generic Injectables Market by Therapeutic Area (Oncology, Anaesthesia, Anti-Infectives, Parenteral Nutrition and Cardiovascular) by Container (Vials, Ampoules, Premix and Prefilled Syringes) and Distribution Channel (Hospitals and Retail Pharmacy Stores): Industry Analysis, Trends, Growth and Forecast 2019-2024



GCC Generic Injectables Market Overview:

The GCC generic injectables market was worth US$ 438 Million in 2018, expanding at a CAGR of 14% during 2011-2018. The market is projected to register a CAGR of 12% during 2019-2024, reaching US$ 865 Million by 2024. The GCC generic injectables market is currently exhibiting a healthy growth. Generic injectables are biologics that provide treatment of various drugs and has the same components as their branded versions. The required regulations and manufacturing processes of these injectables are similar to those of their branded counterparts. Additionally, the R&D required for these injectables do not require huge investments. The production of generic injectables has been an advantage for several manufacturers as governments in various countries of GCC region have promoted the same because of the benefits it offers and its low-cost. Moreover, the number of competitors in the generic injectables market is lower as compared to oral generics, resulting in limited erosion and high profit margins. These medicines are becoming popular on account of several other factors which include expiration of patents of popular drugs, increasing prevalence of chronic and lifestyle diseases, and ageing population. Additionally, the cost of generic injectables is much lower as compared to its counterparts, making it highly affordable for the patients.

GCC Generic Injectables Market Segment Insights:

The report has assessed the GCC generic injectables market. The report has further examined the market based on therapeutic area including, oncology, anaesthesia, anti-infectives, parenteral nutrition and cardiovascular. On the basis of container covering, vials, ampoules, premix and prefilled syringes. On the basis of distribution channel including, hospitals and retail pharmacy stores. On a regional basis, the report examines the generic injectables market in Saudi Arabia, United Arab Emirates, Qatar, Kuwait, Oman and Bahrain. An evaluation of the competitive landscape has also been provided with the details of the key players operating in the GCC generic injectables market.

GCC Generic Injectables Market

Highlights of the GCC Generic Injectables Market Report:

  • Historical and current scenario
  • Trends and developments
  • Market forecast
  • Price analysis and forecast
  • Porter’s five forces analysis
  • SWOT analysis
  • Value chain analysis

Key Market Segments:

The GCC generic injectables market has been analysed as followed:

Segmentation by Therapeutic Area:

  • Oncology
  • Anaesthesia
  • Anti-infectives
  • Parenteral Nutrition
  • Cardiovascular

Based on therapeutic areas, oncology represents the leading segment for generic injectables, accounting for the majority of the total market share. Rising cases of cancer along with patent expiry of oncology drugs are boosting the demand for generic injectables

Segmentation by Container:

  • Vials
  • Ampoules
  • Premix
  • Prefilled Syringes

According to the report, vials represent the most popular container type, holding the largest share. Vials are plastic or glass vessels which can be reused to store liquid after cleaning, and offer correct and explicit mark signs that give a visual indicator of the left-over quantity.

Segmentation by Distribution Channel:

  • Hospitals
  • Retail Pharmacy Stores

On the basis of distribution channels, the market has been bifurcated into hospitals and retail pharmacy stores, wherein hospitals exhibit a clear dominance. Generic injectables cannot be traded or administered without medical assistance owing to which they are mostly available in hospitals.

Segmentation by Country:

  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Kuwait
  • Oman
  • Bahrain

Region-wise, Saudi Arabia represents the dominant market, accounting for the majority of the total market share. Domestic generic injectable manufacturers in the region are collaborating with global and regional pharma players to expand their manufacturing capacity.

Report Customisation:

The GCC generic injectables market report can be customised as per your requirements. You can get in touch with our analyst, who will make sure that the report suits your research needs.

1 Introduction
    1.1    Research Objectives 
    1.2    Stakeholders
    1.3    Scope of the Report
    1.4    Assumptions and Limitations
2 Research Methodology 
    2.1    Data Collection
        2.1.1    Primary Sources
        2.1.2    Secondary Sources
    2.2    Market Size Estimation
        2.2.1    Bottom-Up Approach
        2.2.2    Top-Down Approach
    2.3    Data Validation
3 Executive Summary
4 Global Generic Drug Market

    4.1    Historical Market Trend 
    4.2    Market Segmentation by Region 
    4.3    Market Outlook 
    4.4    Major Players 
5 GCC Generic Drug Market Drug Delivery 
    5.1    Oral  
    5.2    Injectables   
    5.3    Dermal/Topical   
    5.4    Inhalers        
6 GCC Generic Injectables Market
    6.1    Industry Overview 
    6.2    Key Industry Developments
    6.3    Market Trends
        6.3.1    Key Market Indicators
        6.3.2    Historical Market Trends
        6.3.3    Market Outlook
7 GCC Generic Injectables Market Segmentation by Country
    7.1    Saudi Arabia  
        7.1.1    Historical Market Trends
        7.1.2    Market Outlook
    7.2    United Arab Emirates   
        7.2.1    Historical Market Trends
        7.2.2    Market Outlook
    7.3    Qatar 
        7.3.1    Historical Market Trends
        7.3.2    Market Outlook
    7.4    Kuwait 
        7.4.1    Historical Market Trends
        7.4.2    Market Outlook
    7.5    Oman 
        7.5.1    Historical Market Trends
        7.5.2    Market Outlook
    7.6    Bahrain 
        7.6.1    Historical Market Trends
        7.6.2    Market Outlook
8 GCC Generic Injectables Market Segmentation by Therapeutic Area
    8.1    Oncology
        8.1.1    Historical Market Trends
        8.1.2    Market Outlook
    8.2    Anaesthesia
        8.2.1    Historical Market Trends
        8.2.2    Market Outlook
    8.3    Anti-infectives
        8.3.1    Historical Market Trends
        8.3.2    Market Outlook
    8.4    Parenteral Nutrition
        8.4.1    Historical Market Trends
        8.4.2    Market Outlook
    8.5    Cardiovascular
        8.5.1    Historical Market Trends
        8.5.2    Market Outlook
9 GCC Generic Injectables Market Segmentation by Container
    9.1     Vials
        9.1.1    Historical Market Trends
        9.1.2    Market Outlook
    9.2   Ampoules
        9.2.1    Historical Market Trends
        9.2.2    Market Outlook
    9.3   Premix   
        9.3.1    Historical Market Trends
        9.3.2    Market Outlook
    9.4   Prefilled Syringes   
        9.4.1    Historical Market Trends
        9.4.2    Market Outlook
10 GCC Generic Injectables Market Segmentation by Distribution Channel
    10.1    Hospitals
        10.1.1    Historical Market Trends
        10.1.2    Market Outlook
    10.2    Retail Pharmacy Stores
        10.2.1    Historical Market Trends
        10.2.2    Market Outlook
11 GCC Generic Injectables Industry: Market Dynamics
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses 
    11.4    Opportunities
    11.5    Threats
12 GCC Generic Injectables Industry: Value Chain Analysis
    12.1    Overview
    12.2    Research and Development
    12.3    Raw Material Suppliers
    12.4    Inbound Logistics
    12.5    Production
    12.6    Marketing 
    12.7    Outbound Logistics
    12.8    Consumers 
13 GCC Generic Injectables Industry: Porter’s Five Forces Analysis
    13.1    Overview
    13.2    Threat of New Entrants
    13.3    Threat of Substitutes
    13.4    Bargaining Power of Buyers
    13.5    Bargaining Power of Suppliers
    13.6    Intensity of Rivalry
14 Competitive Landscape
    14.1    Market Structure
    14.2    Key Players 
    14.3    Key Success Factors 
15 Key Player Profiles

List of Figures

Figure 1: Global: Generic Drug Market: Sales Value (in Billion US$), 2011-2018
Figure 2: Global: Generic Drug Market: Segmentation by Region (in %), 2018
Figure 3: Global: Generic Drug Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 4: GCC: Generic Drug Market : Sales Value (in Billion US$), 2011-2018
Figure 5: GCC: Generic Drug Market: Segmentation by Drug Delivery (in %), 2018
Figure 6: GCC: Generic Drug Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 7: GCC: Generic Injectables Market: Sales Value (in Million US$), 2011-2018
Figure 8: GCC: Generic Injectables Market Outlook: Sales Value (in Billion US$), 2019-2024
Figure 9: GCC: Generic Injectables Market: Segmentation by Country (in %), 2018
Figure 10: GCC: Generic Injectables Market: Segmentation by Therapeutic Area (in %), 2018
Figure 11: GCC: Generic Injectables Market: Segmentation by Container (in %), 2018
Figure 12: GCC: Generic Injectables Market: Segmentation by Distribution Channel (in %), 2018
Figure 13: Saudi Arabia: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 14: Saudi Arabia: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 15: United Arab Emirates: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 16: United Arab Emirates: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 17: Qatar: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 18: Qatar: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 19: Kuwait: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 20: Kuwait: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 21: Oman: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 22: Oman: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 23: Bahrain: Generic Injectables Market: Sales Value (in Million US$), 2011 & 2018
Figure 24: Bahrain: Generic Injectables Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 25: GCC: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2011 & 2018
Figure 26: GCC: Generic Injectables (Oncology) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 27: GCC: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2011 & 2018
Figure 28: GCC: Generic Injectables (Anaesthesia) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 29: GCC: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2011 & 2018
Figure 30: GCC: Generic Injectables (Anti-infectives) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 31: GCC: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2011 & 2018
Figure 32: GCC: Generic Injectables (Parenteral Nutrition) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 33: GCC: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2011 & 2018
Figure 34: GCC: Generic Injectables (Cardiovascular) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 35: GCC: Generic Injectables (Vials) Market: Sales Value (in Million US$), 2011 & 2018
Figure 36: GCC: Generic Injectables (Vials) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 37: GCC: Generic Injectables (Ampoules) Market: Sales Value (in Million US$), 2011 & 2018    
Figure 38: GCC: Generic Injectables (Ampoules) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 39: GCC: Generic Injectables (Premix) Market: Sales Value (in Million US$), 2011 & 2018
Figure 40: GCC: Generic Injectables (Premix) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 41: GCC: Generic Injectables (Prefilled Syringes) Market: Sales Value (in Million US$), 2011 & 2018
Figure 42: GCC: Generic Injectables (Prefilled Syringes) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 43: GCC: Generic Injectables (Hospitals) Market: Sales Value (in Million US$), 2011 & 2018
Figure 44: GCC: Generic Injectables (Hospitals) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 45: GCC: Generic Injectables (Retail Pharmacy Stores) Market: Sales Value (in Million US$), 2011 & 2018
Figure 46: GCC: Generic Injectables (Retail Pharmacy Stores) Market Outlook: Sales Value (in Million US$), 2019-2024
Figure 47: GCC: Generic Injectables Industry: Market Dynamics
Figure 48: GCC: Generic Injectables Industry: Value Chain Analysis
Figure 49: GCC: Generic Injectables Market: Porter’s Five Forces Analysis

List of Tables

Table 1: GCC: Generic Injectables Market: Key Industry Highlights, 2018 and 2024
Table 2: GCC: Generic Injectables Market Outlook: Segmentation by Country (in Million US$), 2019-2024
Table 3: GCC: Generic Injectables Market Outlook: Segmentation by Therapeutic Area (in Million US$), 2019-2024
Table 4: GCC: Generic Injectables Market Outlook: Segmentation by Container (in Million US$), 2019-2024
Table 5: GCC: Generic Injectables Market Outlook: Segmentation by Distribution Channel (in Million US$), 2019-2024
Table 6: GCC: Generic Injectables Market Structure
Table 7: GCC: Generic Injectables Market: Key Players

Special Prices


    Syndicated Analytics provides special pricing for:

  • Academic Institutes
  • Government Agencies
  • Nonprofit Organizations

  • For more information, feel free to contact us.





Related Reports

Garbage Bags Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Garbage Bags manufacturing plant covering the essential techno-commercial aspects

Sanitary Napkins Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Sanitary Napkins manufacturing plant covering the essential techno-commercial aspects.

Surgical Gloves Prefeasibility Analysis Report 2019

The report offers an in-depth roadmap or setting up a Surgical Gloves manufacturing plant covering the essential techno-commercial aspects

Linear Alkylbenzene Sulfonate Production Cost Analysis Report 2019

This production cost analysis report by Syndicated Analytics is the result of comprehensive examination of the Linear Alkylbenzene Sulfonate manufacturing process

GCC Healthcare Information Software Market by Development (On-Premise and Cloud) and Application (Hospitals, Clinics, Medical Research Centers and others):Industry Analysis, Trends, Growth and Forecast 2019-2024

The GCC Healthcare Information Software Market was worth US$ XX Billion in 2018, expanding at a CAGR of X% during 2011-2018. The market is projected to register a CAGR of X% during 2019-2024, reaching US$ XX Billion by 2024.